Brief: ASP Isotopes And IsoBio Announce Series Seed Funding Of Isobio To Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment
28/07/2025 13:49
July 28 (Reuters) - ASP Isotopes Inc ASPI.O: ASP ISOTOPES INC. AND ISOBIO, INC. ANNOUNCE SERIES SEED FUNDING OF ISOBIO, INC. TO ADVANCE INNOVATIVE ANTIBODY-ISOTOPE CONJUGATES (AICSTM) FOR CANCER TREATMENT Source text: ID:nGNX18Cw5w Further company coverage: ASPI.O (Reporting by Anshi Sancheti) ((Anshi.Sancheti@thomsonreuters.com;))
Recent news on ASP Isotopes
See all newsBrief: ASP Isotopes Says Co Targets More Than $300 Mln Of Ebitda In 2031
Brief: ASP Isotopes Says Renergen Limited’s Unit Commenced Commissioning Of Liquid Helium Plant
Brief: Asp Isotopes - Announces Qle Evaluating Metal Conversion Opportunities In Namibia
ASP Isotopes Inc reports results for the quarter ended June 30 - Earnings Summary
Australia's Kinetiko seeks fast-track route to South Africa gas production